iShares Genomics Immunology and Healthcare ETF (IDNA) |
| 40.96 0.42 (1.04%) 10-19 16:00 |
| Open: | 40.74 |
| High: | 41.735 |
| Low: | 40.74 |
| Volume: | 214,249 |
| Market Cap: | 192(M) |
| PE Ratio: | 14.58 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 50.74 |
| Resistance 1: | 43.44 |
| Pivot price: | 41.50 |
| Support 1: | 40.18 |
| Support 2: | 38.17 |
| 52w High: | 43.44 |
| 52w Low: | 24.29 |
The iShares Genomics Immunology and Healthcare ETF (IDNA) is designed to mirror the investment performance of a specific index. This index comprises companies operating in both mature and emerging global markets. These businesses are strategically chosen for their potential to capitalize on sustained innovation and expansion within the crucial fields of genomics, immunology, and bioengineering.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Mon, 12 Oct 2026
Precision Trading with Ishares Genomics Immunology And Healthcare Etf (IDNA) Risk Zones - Stock Traders Daily
Fri, 02 Oct 2026
Understanding Momentum Shifts in (IDNA) - Stock Traders Daily
Fri, 21 Aug 2026
IDNA ETF: 3 Catalysts To Watch Closely (NYSEARCA:IDNA) - Seeking Alpha
Wed, 19 Aug 2026
Healthcare ETFs rally as Moderna nearly doubles on melanoma win - Seeking Alpha
Wed, 19 Aug 2026
Merck, Moderna Cancer Vaccine Breakthrough Puts 4 ETFs In Focus - Merck & Co (NYSE:MRK) - Benzinga
Wed, 12 Aug 2026
5 Best CRISPR Gene Editing ETFs for 2026 and How to Invest - The Motley Fool
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
